Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marta Ferran

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Experimental Dermatology|June 27, 2013
Circulating CLA+ T lymphocytes as peripheral cell biomarkers in T-cell-mediated skin diseasesMarta Ferran, Ester R Romeu, Catalina Rincón, et al.
Acta Dermato-Venereologica|January 11, 2019
Patients with Moderate to Severe Psoriasis Associate with Higher Risk of Depression and Anxiety Symptoms: Results of a Multivariate Study of 300 Spanish Individuals with PsoriasisMaria José Tribó, Marta Turroja, Gemma Castaño-Vinyals, et al.
The Journal of Investigative Dermatology|November 30, 2012
Streptococcus induces circulating CLA(+) memory T-cell-dependent epidermal cell activation in psoriasisMarta Ferran, Ana B Galván, Catalina Rincón, et al.
Clinical and Experimental Dermatology|April 13, 2026
Successful Treatment of Severe Refractory Chronic Actinic Dermatitis with Upadacitinib: A Case Series of Four PatientsNidia Planella-Fontanillas, Jorge Magdaleno-Tapial, Vicente Expósito-Serrano, et al.
The Journal of Investigative Dermatology|January 24, 2020
Specific IgA and CLA<sup>+</sup> T-Cell IL-17 Response to Streptococcus pyogenes in PsoriasisCarmen De Jesús-Gil, Lidia Sans-de San Nicolás, Ester Ruiz-Romeu, et al.
The Journal of Dermatological Treatment|May 20, 2022
Survival of guselkumab therapy in moderate to severe plaque psoriasis at 52 weeks in a real-world clinical setting: observational, retrospective, multi-centre study by the Spanish Psoriasis GroupElena Del Alcázar, Anna López-Ferrer, Álvaro Martínez-Doménech, et al.
Nanomaterials (Basel, Switzerland)|July 5, 2017
Biodegradable FeMnSi Sputter-Coated Macroporous Polypropylene Membranes for the Sustained Release of DrugsJordina Fornell, Jorge Soriano, Miguel Guerrero, et al.
The Journal of Dermatological Treatment|March 19, 2019
Effectiveness and safety of ustekinumab 90 mg in patients weighing 100 kg or less: a retrospective, observational, multicenter studyElena Del Alcázar, Marta Ferran, Anna López-Ferrer, et al.
The Journal of Investigative Dermatology|May 16, 2016
MCPIP1 RNase Is Aberrantly Distributed in Psoriatic Epidermis and Rapidly Induced by IL-17AEster Ruiz-Romeu, Marta Ferran, Ana Giménez-Arnau, et al.
The Journal of Investigative Dermatology|October 22, 2017
Microbe-Dependent Induction of IL-9 by CLA<sup>+</sup> T Cells in Psoriasis and Relationship with IL-17AEster Ruiz-Romeu, Marta Ferran, Carmen de Jesús-Gil, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Experimental Dermatology|June 27, 2013
Circulating CLA+ T lymphocytes as peripheral cell biomarkers in T-cell-mediated skin diseasesMarta Ferran, Ester R Romeu, Catalina Rincón, et al.
Acta Dermato-Venereologica|January 11, 2019
Patients with Moderate to Severe Psoriasis Associate with Higher Risk of Depression and Anxiety Symptoms: Results of a Multivariate Study of 300 Spanish Individuals with PsoriasisMaria José Tribó, Marta Turroja, Gemma Castaño-Vinyals, et al.
The Journal of Investigative Dermatology|November 30, 2012
Streptococcus induces circulating CLA(+) memory T-cell-dependent epidermal cell activation in psoriasisMarta Ferran, Ana B Galván, Catalina Rincón, et al.
Clinical and Experimental Dermatology|April 13, 2026
Successful Treatment of Severe Refractory Chronic Actinic Dermatitis with Upadacitinib: A Case Series of Four PatientsNidia Planella-Fontanillas, Jorge Magdaleno-Tapial, Vicente Expósito-Serrano, et al.
The Journal of Investigative Dermatology|January 24, 2020
Specific IgA and CLA<sup>+</sup> T-Cell IL-17 Response to Streptococcus pyogenes in PsoriasisCarmen De Jesús-Gil, Lidia Sans-de San Nicolás, Ester Ruiz-Romeu, et al.
The Journal of Dermatological Treatment|May 20, 2022
Survival of guselkumab therapy in moderate to severe plaque psoriasis at 52 weeks in a real-world clinical setting: observational, retrospective, multi-centre study by the Spanish Psoriasis GroupElena Del Alcázar, Anna López-Ferrer, Álvaro Martínez-Doménech, et al.
Nanomaterials (Basel, Switzerland)|July 5, 2017
Biodegradable FeMnSi Sputter-Coated Macroporous Polypropylene Membranes for the Sustained Release of DrugsJordina Fornell, Jorge Soriano, Miguel Guerrero, et al.
The Journal of Dermatological Treatment|March 19, 2019
Effectiveness and safety of ustekinumab 90 mg in patients weighing 100 kg or less: a retrospective, observational, multicenter studyElena Del Alcázar, Marta Ferran, Anna López-Ferrer, et al.
The Journal of Investigative Dermatology|May 16, 2016
MCPIP1 RNase Is Aberrantly Distributed in Psoriatic Epidermis and Rapidly Induced by IL-17AEster Ruiz-Romeu, Marta Ferran, Ana Giménez-Arnau, et al.
The Journal of Investigative Dermatology|October 22, 2017
Microbe-Dependent Induction of IL-9 by CLA<sup>+</sup> T Cells in Psoriasis and Relationship with IL-17AEster Ruiz-Romeu, Marta Ferran, Carmen de Jesús-Gil, et al.
Pageof 5